Viewing
News|Articles|June 22, 2026

Faricimab (Vabysmo® , Roche Products Ltd) for visual impairment due to macular oedema secondary to retinal vein occlusion: An educational supplement

This is a promotional supplement commissioned by Roche Products Limited.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME